LANDMARK trial: Update in statistical analytical plan and protocol for the 1-year report
- 11 April 2025
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 288, 26-27
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic AnnulusNew England Journal of Medicine, 2024
- LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trialThe Lancet, 2024
- LANDMARK trial: Update in study protocolAmerican Heart Journal, 2024
- Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical researchEuropean Heart Journal, 2021
- Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trialAmerican Heart Journal, 2021
- Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic StenosisCirculation, 2020
- Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic StenosisJAMA, 2018